GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio Preventive Medicine Corp (ROCO:6810) » Definitions » Research & Development

Bio Preventive Medicine (ROCO:6810) Research & Development : NT$46.81 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bio Preventive Medicine Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bio Preventive Medicine's Research & Development for the six months ended in Jun. 2024 was NT$24.17 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was NT$46.81 Mil.

Bio Preventive Medicine Research & Development Historical Data

The historical data trend for Bio Preventive Medicine's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Preventive Medicine Research & Development Chart

Bio Preventive Medicine Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 50.57 47.06 43.87 44.72 42.91

Bio Preventive Medicine Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 24.46 20.27 20.27 22.64 24.17

Bio Preventive Medicine Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$46.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Preventive Medicine  (ROCO:6810) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bio Preventive Medicine Research & Development Related Terms

Thank you for viewing the detailed overview of Bio Preventive Medicine's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio Preventive Medicine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio Preventive Medicine Corp (ROCO:6810) » Definitions » Research & Development
Comparable Companies
ROCO:6610 ROCO:6872 ROCO:6850 ROCO:4192 ROCO:3205 ROCO:6652 ROCO:6709 ROCO:6236 ROCO:6827 ROCO:4186 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Website
https://www.bpmbiotech.com
Bio Preventive Medicine Corp is an innovative clinical-staged biotech company, focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product.

Bio Preventive Medicine Headlines

No Headlines